(Q47719898)

English

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

Carsten Denkert

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Wolfgang D Schmitt

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Gunter von Minckwitz

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

B M Müller

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

H Eidtmann

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

W Eiermann

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

B Gerber

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

H Tesch

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J Hilfrich

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J Huober

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

T Fehm

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J Barinoff

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

C Jackisch

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J Prinzler

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

T Rüdiger

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

E Erbstösser

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J U Blohmer

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

J Budczies

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

K M Mehta

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

S Loibl

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

22 August 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2786-2793

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23970015%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Proliferation marker Ki-67 in early breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Ki67 in breast cancer: prognostic and predictive potential

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT350

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47719898&oldid=1372721861"